LTC3214083I2 - Kvinolono junginių gamybos būdas - Google Patents

Kvinolono junginių gamybos būdas

Info

Publication number
LTC3214083I2
LTC3214083I2 LTPA2021002C LTPA2021002C LTC3214083I2 LT C3214083 I2 LTC3214083 I2 LT C3214083I2 LT PA2021002 C LTPA2021002 C LT PA2021002C LT PA2021002 C LTPA2021002 C LT PA2021002C LT C3214083 I2 LTC3214083 I2 LT C3214083I2
Authority
LT
Lithuania
Prior art keywords
quinolon
compounds
production
quinolon compounds
Prior art date
Application number
LTPA2021002C
Other languages
English (en)
Original Assignee
Melinta Subsidiary Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Subsidiary Corp. filed Critical Melinta Subsidiary Corp.
Publication of LTPA2021002I1 publication Critical patent/LTPA2021002I1/lt
Publication of LTC3214083I2 publication Critical patent/LTC3214083I2/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
LTPA2021002C 2008-09-24 2021-02-17 Kvinolono junginių gamybos būdas LTC3214083I2 (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19408308P 2008-09-24 2008-09-24
EP09816565.7A EP2346855B1 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds
PCT/US2009/005276 WO2010036329A2 (en) 2008-09-24 2009-09-23 Process for making quinolone compounds

Publications (2)

Publication Number Publication Date
LTPA2021002I1 LTPA2021002I1 (lt) 2021-03-10
LTC3214083I2 true LTC3214083I2 (lt) 2022-06-27

Family

ID=42060333

Family Applications (3)

Application Number Title Priority Date Filing Date
LTEP20191961.0T LT3766876T (lt) 2008-09-24 2009-09-23 Farmacinė vaisto forma, turinti chinolono darinį
LTEP17163383.7T LT3214083T (lt) 2008-09-24 2009-09-23 Kvinolono junginių gamybos būdas
LTPA2021002C LTC3214083I2 (lt) 2008-09-24 2021-02-17 Kvinolono junginių gamybos būdas

Family Applications Before (2)

Application Number Title Priority Date Filing Date
LTEP20191961.0T LT3766876T (lt) 2008-09-24 2009-09-23 Farmacinė vaisto forma, turinti chinolono darinį
LTEP17163383.7T LT3214083T (lt) 2008-09-24 2009-09-23 Kvinolono junginių gamybos būdas

Country Status (27)

Country Link
US (3) US8497378B2 (lt)
EP (3) EP2346855B1 (lt)
JP (2) JP6013734B2 (lt)
KR (3) KR101775304B1 (lt)
CN (2) CN102164912B (lt)
AU (1) AU2009297085B2 (lt)
BR (1) BRPI0919241B8 (lt)
CA (1) CA2738236C (lt)
CY (1) CY1123658T1 (lt)
DK (2) DK2346855T3 (lt)
ES (2) ES2629466T3 (lt)
FI (1) FI3766876T3 (lt)
HK (2) HK1214243A1 (lt)
HR (1) HRP20201879T1 (lt)
HU (2) HUE052219T2 (lt)
IL (1) IL211845A (lt)
LT (3) LT3766876T (lt)
MX (2) MX2011003122A (lt)
NL (1) NL301091I2 (lt)
NO (1) NO2021006I1 (lt)
PL (2) PL3214083T3 (lt)
PT (1) PT3214083T (lt)
RS (1) RS61194B1 (lt)
RU (1) RU2546667C2 (lt)
SG (1) SG10201605492YA (lt)
SI (1) SI3214083T1 (lt)
WO (1) WO2010036329A2 (lt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576216B2 (en) * 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
ES2629466T3 (es) 2008-09-24 2017-08-09 Melinta Therapeutics, Inc. Proceso para la fabricación de compuestos de quinolona
WO2014152317A2 (en) * 2013-03-15 2014-09-25 Melinta Therapeutics, Inc. Methods of treating gonorrhea infections using quinolone antibiotics
CN104098548B (zh) * 2013-04-11 2017-07-18 上海医药工业研究院 一种Delafloxacin的精制方法
CN103709100A (zh) * 2013-12-31 2014-04-09 南京工业大学 一种8-氯代喹诺酮衍生物的制备方法
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
CN106256824B (zh) * 2015-06-18 2020-10-27 重庆医药工业研究院有限责任公司 一种高纯度德拉沙星葡甲胺盐的制备方法
CN105017224A (zh) * 2015-07-10 2015-11-04 扬子江药业集团有限公司 一种德拉沙星葡甲胺晶型的制备方法
CN107778293B (zh) * 2016-08-29 2023-06-16 鲁南制药集团股份有限公司 一种改进的德拉沙星的制备方法
AU2018246563B2 (en) 2017-03-31 2020-07-30 Fujifilm Corporation 4-Pyridone compound or salt thereof, and pharmaceutical composition and formulation including same
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
CN113527262B (zh) * 2021-06-22 2022-07-15 安徽普利药业有限公司 一种德拉沙星及其葡甲胺盐的精制方法
CN114031607B (zh) * 2021-11-16 2023-01-10 海南普利制药股份有限公司 一种德拉沙星及其中间体的精制方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
BR9612862B8 (pt) 1995-09-22 2014-08-05 Wakunaga Pharma Co Ltd Derivado de ácido piridono carboxílico e agentes antibacteriais.
DK1193266T3 (da) * 1999-07-01 2003-11-24 Wakunaga Pharma Co Ltd Quinolincarboxylsyrederivat eller salte deraf
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
CA2575148C (en) * 2004-07-30 2012-07-17 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
LT3056492T (lt) 2004-10-08 2022-01-25 Abbvie Inc. Meglumino druska ir atitinkamos vaisto (delafloksacino) kristalinės formos
PT1868581E (pt) 2005-04-11 2012-06-22 Abbott Lab Composições farmacêuticas que possuem perfis de dissolução melhorados para fármacos pouco solúveis
ES2629466T3 (es) 2008-09-24 2017-08-09 Melinta Therapeutics, Inc. Proceso para la fabricación de compuestos de quinolona

Also Published As

Publication number Publication date
HK1244481A1 (zh) 2018-08-10
RS61194B1 (sr) 2021-01-29
LT3214083T (lt) 2021-01-25
KR20110091504A (ko) 2011-08-11
RU2546667C2 (ru) 2015-04-10
IL211845A (en) 2017-03-30
KR20170039758A (ko) 2017-04-11
EP3766876A1 (en) 2021-01-20
ES2826273T3 (es) 2021-05-17
EP2346855A2 (en) 2011-07-27
AU2009297085B2 (en) 2015-07-09
BRPI0919241A8 (pt) 2017-10-17
PL3214083T3 (pl) 2021-04-06
NO2021006I1 (no) 2021-02-15
EP3766876B8 (en) 2023-10-18
WO2010036329A3 (en) 2010-07-01
NL301091I2 (nl) 2021-08-03
SI3214083T1 (sl) 2021-02-26
RU2011116052A (ru) 2012-10-27
PL3766876T3 (pl) 2024-04-02
MX2011003122A (es) 2011-07-20
IL211845A0 (en) 2011-06-30
AU2009297085A1 (en) 2010-04-01
CA2738236C (en) 2016-11-15
EP2346855B1 (en) 2017-04-05
ES2629466T3 (es) 2017-08-09
CN102164912A (zh) 2011-08-24
DK2346855T3 (en) 2017-07-24
BRPI0919241B8 (pt) 2021-05-25
EP3766876B1 (en) 2023-09-13
HRP20201879T1 (hr) 2021-01-22
CN102164912B (zh) 2015-08-19
CA2738236A1 (en) 2010-04-01
HUE052219T2 (hu) 2021-04-28
CN105001207A (zh) 2015-10-28
CY1123658T1 (el) 2021-05-05
NL301091I1 (nl) 2021-02-10
LTPA2021002I1 (lt) 2021-03-10
JP2015178515A (ja) 2015-10-08
JP2012508161A (ja) 2012-04-05
BRPI0919241A2 (pt) 2016-06-21
PT3214083T (pt) 2020-12-04
KR20160116020A (ko) 2016-10-06
HUS2100004I1 (hu) 2021-03-01
HK1214243A1 (zh) 2016-07-22
SG10201605492YA (en) 2016-09-29
EP2346855A4 (en) 2012-07-04
FI3766876T3 (fi) 2023-12-05
US8871938B2 (en) 2014-10-28
BRPI0919241B1 (pt) 2020-05-12
MX2020009790A (es) 2020-10-12
EP3214083B1 (en) 2020-09-16
LT3766876T (lt) 2023-12-11
JP6013734B2 (ja) 2016-10-25
KR101775304B1 (ko) 2017-09-05
USRE46617E1 (en) 2017-11-28
EP3214083A1 (en) 2017-09-06
DK3214083T3 (da) 2020-12-07
WO2010036329A2 (en) 2010-04-01
US8497378B2 (en) 2013-07-30
US20120041208A1 (en) 2012-02-16
US20140171648A1 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
LTC3214083I2 (lt) Kvinolono junginių gamybos būdas
BRPI0916499A2 (pt) método de produção de biomassa
BRPI0919116A2 (pt) método
BRPI0920540A2 (pt) método de produção de álcool
BRPI0906098A2 (pt) Método de preparação de um composto
DK2313489T3 (da) Fremstillingsmetode
BRPI0922490A2 (pt) Método para produção de beta-santaleno
BR112012014162A2 (pt) método de fabricação de uma nanomanta
EP2315757A4 (en) PREPARATION OF HYDROXYMETHYLFURFUAL
BRPI0923001A2 (pt) método de produção de lipossomas pequenos
BR112013016073A2 (pt) método para produçao de compostos orgânicos
BRPI0916597A2 (pt) Método
IS8917A (is) Aðferð til að smíða skó
DK2346661T3 (da) Dannelsesfremgangsmåder
BRPI0911286A2 (pt) Método aperfeiçoado de produção de biodisel
BRPI0923370A2 (pt) Método para produção de titanossilicato
IS8758A (is) Aðferð til þess að framleiða essítalópram
BRPI0913890A2 (pt) Método para produção de ácido 3-metil-2tiofenocarboxílico
BRPI0815419A2 (pt) Método de produção
DK2294043T3 (da) Fremgangsmåde til fremstilling af glycerolalkyletere
PL385356A1 (pl) Sposób wytwarzania tadalafilu
PL382168A1 (pl) Sposób wytwarzania S-(-)- 8-metoksy -2 tetralolu
TH0801005804B (th) กระบวนการสำหรับการผลิตของ p4o6
TH111701B (th) วิธีการสำหรับการผลิตสารประกอบฟิวแรน
TH123098B (th) กระบวนการผลิตวัตถุที่ต้านอาวุธที่มีการปรับปรุงให้ดีขึ้น